サマリー

ベーチェット病治療薬の世界市場 2024-2028
ベーチェット病治療薬市場は2023-2028年に4億3,757万米ドル成長し、予測期間中のCAGRは6.82%で加速すると予測されます。この調査レポートは、ベーチェット病治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、適応外薬の多用、特効薬指定、希少疾患に対する研究費の増加などが牽引しています。
Technavio社のベーチェット病治療薬市場は以下のように分類されます：
投与経路別
- 経口剤
- 注射剤
製品別
- 低分子
- 生物製剤
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、希少疾患に対する意識の高まりが、今後数年間のベーチェット病治療薬市場の成長を促進する主な要因の1つであると特定しています。また、ベンダー間の戦略的提携や新規治療薬の登場は、市場の大きな需要につながるでしょう。
当レポートでは、ベーチェット病治療薬市場について以下の分野をカバーしています：
- ベーチェット病治療薬市場のサイジング
- ベーチェット病治療薬市場予測
- ベーチェット病治療薬市場産業分析
本レポートでは、ベーチェット病治療薬市場の主要ベンダー（AbbVie Inc.、Amgen Inc.、F. Hoffmann La Roche Ltd.、Johnson and Johnson、三菱化学グループ、Novartis AG、Pfizer Inc.、武田薬品工業、Viatris Inc.など）の詳細な分析を掲載しています。武田薬品工業株式会社、ヴィアトリス株式会社、ゾーマ株式会社。また、ベーチェット病治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/behcet-s-disease-therapeutics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global Behcets disease therapeutics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global behcets disease therapeutics market 2018 - 2022 ($ million)
o 4.2 Route of Administration Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
o 4.3 Product Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Oral - Market size and forecast 2023-2028
o Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 6.4 Injectable - Market size and forecast 2023-2028
o Exhibit 38: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Injectable - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 44: Chart on Product - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 46: Chart on Comparison by Product
o Exhibit 47: Data Table on Comparison by Product
o 7.3 Small molecules - Market size and forecast 2023-2028
o Exhibit 48: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
o 7.4 Biologics - Market size and forecast 2023-2028
o Exhibit 52: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Biologics - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Product
o Exhibit 56: Market opportunity by Product ($ million)
o Exhibit 57: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Japan - Market size and forecast 2023-2028
o Exhibit 83: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.9 UK - Market size and forecast 2023-2028
o Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 107: AbbVie Inc. - Overview
o Exhibit 108: AbbVie Inc. - Product / Service
o Exhibit 109: AbbVie Inc. - Key news
o Exhibit 110: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 111: Amgen Inc. - Overview
o Exhibit 112: Amgen Inc. - Product / Service
o Exhibit 113: Amgen Inc. - Key offerings
o 12.5 F. Hoffmann La Roche Ltd.
o Exhibit 114: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 116: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus
o 12.6 Johnson and Johnson
o Exhibit 119: Johnson and Johnson - Overview
o Exhibit 120: Johnson and Johnson - Business segments
o Exhibit 121: Johnson and Johnson - Key news
o Exhibit 122: Johnson and Johnson - Key offerings
o Exhibit 123: Johnson and Johnson - Segment focus
o 12.7 Mitsubishi Chemical Group Corp.
o Exhibit 124: Mitsubishi Chemical Group Corp. - Overview
o Exhibit 125: Mitsubishi Chemical Group Corp. - Business segments
o Exhibit 126: Mitsubishi Chemical Group Corp. - Key offerings
o Exhibit 127: Mitsubishi Chemical Group Corp. - Segment focus
o 12.8 Novartis AG
o Exhibit 128: Novartis AG - Overview
o Exhibit 129: Novartis AG - Business segments
o Exhibit 130: Novartis AG - Key offerings
o Exhibit 131: Novartis AG - Segment focus
o 12.9 Pfizer Inc.
o Exhibit 132: Pfizer Inc. - Overview
o Exhibit 133: Pfizer Inc. - Product / Service
o Exhibit 134: Pfizer Inc. - Key news
o Exhibit 135: Pfizer Inc. - Key offerings
o 12.10 Takeda Pharmaceutical Co. Ltd.
o Exhibit 136: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 137: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 138: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 139: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.11 Viatris Inc.
o Exhibit 140: Viatris Inc. - Overview
o Exhibit 141: Viatris Inc. - Business segments
o Exhibit 142: Viatris Inc. - Key news
o Exhibit 143: Viatris Inc. - Key offerings
o Exhibit 144: Viatris Inc. - Segment focus
o 12.12 Xoma Corp.
o Exhibit 145: Xoma Corp. - Overview
o Exhibit 146: Xoma Corp. - Product / Service
o Exhibit 147: Xoma Corp. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 148: Inclusions checklist
o Exhibit 149: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 150: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 151: Research methodology
o Exhibit 152: Validation techniques employed for market sizing
o Exhibit 153: Information sources
o 13.5 List of abbreviations
o Exhibit 154: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global behcets disease therapeutics market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Product - Market share 2023-2028 (%)
Exhibits45: Data Table on Product - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ million)
Exhibits57: Data Table on Market opportunity by Product ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. - Overview
Exhibits108: AbbVie Inc. - Product / Service
Exhibits109: AbbVie Inc. - Key news
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Amgen Inc. - Overview
Exhibits112: Amgen Inc. - Product / Service
Exhibits113: Amgen Inc. - Key offerings
Exhibits114: F. Hoffmann La Roche Ltd. - Overview
Exhibits115: F. Hoffmann La Roche Ltd. - Business segments
Exhibits116: F. Hoffmann La Roche Ltd. - Key news
Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits119: Johnson and Johnson - Overview
Exhibits120: Johnson and Johnson - Business segments
Exhibits121: Johnson and Johnson - Key news
Exhibits122: Johnson and Johnson - Key offerings
Exhibits123: Johnson and Johnson - Segment focus
Exhibits124: Mitsubishi Chemical Group Corp. - Overview
Exhibits125: Mitsubishi Chemical Group Corp. - Business segments
Exhibits126: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits127: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits128: Novartis AG - Overview
Exhibits129: Novartis AG - Business segments
Exhibits130: Novartis AG - Key offerings
Exhibits131: Novartis AG - Segment focus
Exhibits132: Pfizer Inc. - Overview
Exhibits133: Pfizer Inc. - Product / Service
Exhibits134: Pfizer Inc. - Key news
Exhibits135: Pfizer Inc. - Key offerings
Exhibits136: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits137: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits138: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits139: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits140: Viatris Inc. - Overview
Exhibits141: Viatris Inc. - Business segments
Exhibits142: Viatris Inc. - Key news
Exhibits143: Viatris Inc. - Key offerings
Exhibits144: Viatris Inc. - Segment focus
Exhibits145: Xoma Corp. - Overview
Exhibits146: Xoma Corp. - Product / Service
Exhibits147: Xoma Corp. - Key offerings
Exhibits148: Inclusions checklist
Exhibits149: Exclusions checklist
Exhibits150: Currency conversion rates for US$
Exhibits151: Research methodology
Exhibits152: Validation techniques employed for market sizing
Exhibits153: Information sources
Exhibits154: List of abbreviations